"I believe close collaboration between TIP and a pediatric pulmonologist makes a significant difference for these groups of patients, and by treating food and environmental allergies and asthma simultaneously, we can make a great impact on these patients' lives."
Omar Yamak, M.D
Attending Physician, Allergy and Immunology
"It [collaborating with FAI] tends to improve patients quality of life and by simultaneously starting SLIT, it improves allergic rhinitis and asthma as well! "
Steven Abelowitz
MD, Pediatrics
“The primary challenges my patients encounter with food allergies are lifestyle limitations, anxiety, and fear related to the dangers of food allergy, especially anaphylaxis, multiple doctor and ER visits, consistent need for medication refills, especially Epipens and Avi-Q, as well as the constant, tedious need to constantly
Complete medical forms such as school allergy and medication administration forms. Witnessing a patient overcoming their allergies is especially rewarding and heartwarming, knowing the dramatic life-changing effect it will have. Some of the notable changes I observe when children reach remission is an overwhelming sense of relief by the patient but especially the parents, increased confidence, and reduced anxiety.”
Michael Villadelgado
MD, Fellow of the American Academy of Pediatrics (FAAP)
“As a healthcare provider, I've always strived to offer the best possible care and options to my patients, especially those with food allergies. Referring them to the Tolerance Induction Program for many years has been educational, life-changing, and revolutionary. Witnessing the remarkable results that my patients have achieved under their expert care has been nothing short of inspiring. Their unique process of introducing biosimilar proteins initially and the unique delivery system in place has been highly effective with lower adverse events and higher compliance among my patients. From reducing and eliminating the severity of allergic reactions to expanding dietary options, the outcomes have been transformative in the lives of many children.
Collaborating with Dr. Randhawa and his dedicated team reinforces my confidence in providing comprehensive care and ensuring my patients receive the highest standard of treatment available.”
Joseph Statos
DO, Pediatric Pulmonology
"Collaborating with the Food Allergy Institute has been a great experience both taking care of FAI patients in TIP and when I see them as a pulmonary consultation. I believe close collaboration between TIP and pediatric pulmonologists makes a significant difference for this group of patients. By treating food and environmental allergies and asthma simultaneously, we can make a great impact on these patients’ life."
Atoosha Kourosh
MD, Pediatrics, Allergy, & Immunology
"Food Allergy Institute's comprehensive evidence-based approach takes the guesswork and fear out of food allergen immunotherapy for families who believe in a science-based approach to healing food allergies and are ready to get started. I feel confident referring to their program and co-managing my patients with the FAI team. I share their precision medicine philosophy and look forward to learning more about my patients and about the unfolding science of oral immunotherapy through their research insights."
Providers FAQs
Clinical questions about protocols, patient selection, and treatment management.
TIP offers a safer, more advanced, and personalized path to food freedom compared to OIT’s desensitization-based approach.
Safety– TIP is designed to be safer, minimizing reaction risk through a data-driven, personalized approach, whereas OIT carries a higher risk of allergic reactions due to direct allergen exposure. Treatment Goal – TIP aims for true remission, allowing patients to eat freely without ongoing maintenance, while OIT focuses on desensitization, requiring lifelong daily dosing to maintain tolerance.
Personalization– TIP uses AI-driven immune profiling to customize treatment for each patient based on biomarkers, whereas OIT follows a standardized protocol for individual allergens.
Multi-Allergen Treatment– TIP treats multiple food allergies simultaneously, while OIT typically targets one allergen at a time.
Diagnostic Testing & Monitoring– TIP relies on advanced diagnostics (IgE, IgG4, skin prick, basophil activation tests) to track immune shifts, while OIT has limited ongoing immune monitoring.
Dosing & Lifestyle Impact– TIP eliminates lifelong dosing and rest periods, allowing a more flexible lifestyle, whereas OIT requires strict daily dosing and and activity restrictions.
TIP is for patients with IgE-mediated food allergies, regardless of severity or preexisting conditions.
Ideal candidates include children and young adults with multiple food allergies or a history of severe reactions, seeking a long-term solution beyond avoidance.
TPIRC, our research branch and parent company, operates as a cutting-edge medical research institute focused on advancing treatments for food allergies and rare orphan disease. It conducts clinical research, develops diagnostic tools, and through the Baric Data Loop, generates the data that powers TIP’s precision-based approach. By continuously analyzing patient outcomes and refining treatment protocols, TPIRC helps improve safety, efficacy, and long-term success for food allergy patients.
TIP, along with our diagnostic lab, research facility, and biobank, follows regulated standards set by the FDA and is overseen by our Institutional Review Board (IRB) Advarra, ensuring the highest levels of safety and compliance. We are also accredited and regulated by CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), the California Department of Public Health, the U.S. Department of Health and Human Services, and the Medical Board of California. Additionally, our food lab's gummy doses are sent to a third party to verify the accurate protein dosage in each gummy.
.png)
.png)
.png)
.png)
